Case | Image 1 | Image 2 | Image 3 | Image 4 | Image 5 | Image 6 | Image 7 | Image 8 | Image 9 |
---|
1 | 17.9 | 45.2 | 44.1 | 12.3 | 8.6 | 41.8 | 31.6 | - | - |
2 | 44.9 | 19.0 | 16.1 | - | - | - | - | - | - |
3 | 8.0 | 5.5 | - | - | - | - | - | - | - |
4 | 4.7 | 5.1 | - | - | - | - | - | - | - |
5 | 31.0 | 22.9 | 430 | 32.9 | 68.7 | 58.9 | 71.0 | 60.8 | 49.5 |
6 | 9.9 | 15.7 | 3.3 | 4.4 | - | - | - | - | - |
7 | 81.7a
| 11.6 | 9.0 | 11.2 | 13.1 | 14.4 | - | - | - |
- The biopsies had approximately the same size 10-20 mm2 but the number of areas with tumour cells and necrotic tissue varied. Between two to nine 320 × 250-μm areas with tumour cells, necrotic tissue, and high TS1 binding per case were analysed. The percentage (%) DAB-positive immunostaining for TS1 in seven cases of primary bronchial small-cell carcinomas was determined by use of ImageJ ImmunoRatio.aContains many intact tumour cells.